-+ 0.00%
-+ 0.00%
-+ 0.00%

Opus Genetics Q4 EPS $(0.21) Misses $(0.12) Estimate, Sales $3.865M Beat $3.649M Estimate

Benzinga·03/10/2026 11:26:06
Listen to the news
Opus Genetics (NASDAQ:IRD) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.12) by 70.73 percent. This is a 83.46 percent increase over losses of $(1.27) per share from the same period last year. The company reported quarterly sales of $3.865 million which beat the analyst consensus estimate of $3.649 million by 5.92 percent. This is a 10.16 percent decrease over sales of $4.302 million the same period last year.